220 related articles for article (PubMed ID: 8540349)
1. Identification of amino acid residues of the retroviral aspartic proteinases important for substrate specificity and catalytic efficiency.
Cameron CE; Burstein H; Bizub-Bender D; Ridky T; Weber IT; Wlodawer A; Skalka AM; Leis J
Adv Exp Med Biol; 1995; 362():399-406. PubMed ID: 8540349
[No Abstract] [Full Text] [Related]
2. Molecular modeling of the structure of FIV protease.
Gustchina A
Adv Exp Med Biol; 1995; 362():479-84. PubMed ID: 8540361
[No Abstract] [Full Text] [Related]
3. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
Tözsér J; Zahuczky G; Bagossi P; Louis JM; Copeland TD; Oroszlan S; Harrison RW; Weber IT
Eur J Biochem; 2000 Oct; 267(20):6287-95. PubMed ID: 11012683
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
[No Abstract] [Full Text] [Related]
5. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
[TBL] [Abstract][Full Text] [Related]
6. Activities of precursor and tethered dimer forms of HIV proteinase.
Phylip LH; Griffiths JT; Mills JS; Graves MC; Dunn BM; Kay J
Adv Exp Med Biol; 1995; 362():467-72. PubMed ID: 8540359
[No Abstract] [Full Text] [Related]
7. A quantum mechanical model of the hydration and acidity of the active site in aspartic proteases.
Topol IA; Cachau RE; Burt SK; Erickson JW
Adv Exp Med Biol; 1995; 362():549-54. PubMed ID: 8540370
[No Abstract] [Full Text] [Related]
8. X-ray structures of retroviral proteases and their inhibitor-bound complexes.
Ringe D
Methods Enzymol; 1994; 241():157-77. PubMed ID: 7854176
[No Abstract] [Full Text] [Related]
9. HIV protease: a novel chemotherapeutic target for AIDS.
Huff JR
J Med Chem; 1991 Aug; 34(8):2305-14. PubMed ID: 1875332
[No Abstract] [Full Text] [Related]
10. Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.
Powell DJ; Bur D; Wlodawer A; Gustchina A; Payne SL; Dunn BM; Kay J
Eur J Biochem; 1996 Oct; 241(2):664-74. PubMed ID: 8917470
[TBL] [Abstract][Full Text] [Related]
11. Subsite preferences of retroviral proteinases.
Dunn BM; Gustchina A; Wlodawer A; Kay J
Methods Enzymol; 1994; 241():254-78. PubMed ID: 7854181
[No Abstract] [Full Text] [Related]
12. Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.
Ridky TW; Kikonyogo A; Leis J; Gulnik S; Copeland T; Erickson J; Wlodawer A; Kurinov I; Harrison RW; Weber IT
Biochemistry; 1998 Sep; 37(39):13835-45. PubMed ID: 9753473
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.
Cameron CE; Grinde B; Jacques P; Jentoft J; Leis J; Wlodawer A; Weber IT
J Biol Chem; 1993 Jun; 268(16):11711-20. PubMed ID: 8389361
[TBL] [Abstract][Full Text] [Related]
14. Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis.
Culberson JC; Bush BL; Sardana VV
Methods Enzymol; 1994; 241():385-94. PubMed ID: 7854190
[No Abstract] [Full Text] [Related]
15. Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor.
Bhat TN; Baldwin ET; Liu B; Cheng YS; Erickson JW
Nat Struct Biol; 1994 Aug; 1(8):552-6. PubMed ID: 7664084
[TBL] [Abstract][Full Text] [Related]
16. A new way of looking at aspartic proteinase structures: a comparison of pepsin structure to other aspartic proteinases in the near active site region.
Andreeva NS; Bochkarev A; Pechik I
Adv Exp Med Biol; 1995; 362():19-32. PubMed ID: 8540318
[No Abstract] [Full Text] [Related]
17. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
[TBL] [Abstract][Full Text] [Related]
18. Breaking the shackles of the genetic code: engineering retroviral proteases through total chemical synthesis.
Kent SB; Baca M; Elder J; Miller M; Milton R; Milton S; Rao JK; Schnölzer M
Adv Exp Med Biol; 1995; 362():425-38. PubMed ID: 8540353
[No Abstract] [Full Text] [Related]
19. Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.
Ingr M; Uhlíková T; Strísovský K; Majerová E; Konvalinka J
Protein Sci; 2003 Oct; 12(10):2173-82. PubMed ID: 14500875
[TBL] [Abstract][Full Text] [Related]
20. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
Tomasselli AG; Heinrikson RL
Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
